Pharmerica Corp (PMC) financial statements (2020 and earlier)

Company profile

Business Address 1901 CAMPUS PLACE
LOUISVILLE, KY 40299
State of Incorp. DE
Fiscal Year End December 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments523332412
Cash and cash equivalents523332412
Receivables2372196200207
Inventory, net of allowances, customer advances and progress billings215155136110136
Inventory215155136110136
Prepaid expense and other current assets39
Income taxes receivable2 
Other undisclosed current assets3092331337637
Total current assets:552484497412430
Noncurrent Assets
Property, plant and equipment8675716253
Intangible assets, net (including goodwill)580561495419390
Goodwill392371318283268
Intangible assets, net (excluding goodwill)188190178136122
Other noncurrent assets813549
Prepaid expense and other noncurrent assets13
Total noncurrent assets:747670571490456
TOTAL ASSETS:1,3001,1541,068901886
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16713016911885
Accounts payable10772968449
Accrued liabilities272837  
Employee-related liabilities3331353536
Taxes payable  2  
Debt161261313
Other undisclosed current liabilities   219
Total current liabilities:182141176152107
Noncurrent Liabilities
Long-term debt and lease obligation458416345219303
Long-term debt, excluding current maturities458416345219303
Liabilities, other than long-term debt11577775759
Deferred compensation liability, classified  875
Deferred tax liabilities, net272112 32
Other liabilities8957585023
Total noncurrent liabilities:573493422276362
Total liabilities:755634598427469
Stockholders' equity
Stockholders' equity attributable to parent544519478463443
Common stock00000
Treasury stock, value(41)(38)(33)(28)(12)
Additional paid in capital411405394380363
Retained earnings17415211711091
Total stockholders' equity:544519478463443
Other undisclosed liabilities and equity  (8)12(26)
TOTAL LIABILITIES AND EQUITY:1,3001,1541,068901886

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues2,0912,0291,8951,7581,833
Cost of revenue
(Cost of Goods and Services Sold)
(1,765)(1,693)(1,627)(1,503)(1,604)
Other undisclosed gross profit  727271
Gross profit:326335339327300
Operating expenses(275)(251)(265)(249)(247)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
    (1)
Other undisclosed operating loss(13)(30)(44)(23)(3)
Operating income:3854305649
Nonoperating income (expense)  21(5)
Loss from catastrophes  21(5)
Interest and debt expense(10)(7)(14)(11)(10)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (2)(1)5
Income from continuing operations before income taxes:2947164539
Income tax expense(7)(12)(9)(26)(16)
Net income available to common stockholders, diluted:223571923

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:223571923
Comprehensive income, net of tax, attributable to parent:223571923

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: